UMIN000048583Not yet recruiting
Follow-up of the efficacy of topical CG428 for chemotherapy-induced nail damage in breast cancer patients undergoing adjuvant chemotherapy.
Nagasaki Harbor Medical CenterUniversity Hospital Medical Information Networkother
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- breast cancer
- Study type
- Interventional
- Intervention type
- other
Sponsor & location
- Primary sponsor
- Nagasaki Harbor Medical Center
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Aug 15, 2022
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedMalignant neoplasm: Breast, unspecifiedOther carcinoma in situ of breast
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000048583
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000048583 through Pure Global AI's free database. This phase not specified trial is sponsored by Nagasaki Harbor Medical Center and is currently Not yet recruiting. The study focuses on breast cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.